UK
Healthtech

CoMind

Year Backed:
2021
Stage:
Seed

CoMind is revolutionising brain monitoring and treatment by delivering non-invasive, AI-driven neurotechnology that provides a multidimensional view of brain activity using light. Their groundbreaking solutions empower clinicians with real-time, actionable insights to enhance patient safety, improve outcomes, and transform care across intensive care, surgeries, and emergency settings.

Founders

James Dacombe

CEO, Founder

Christina Franzeskides

COO, Co-Founder